Loading company…
Scilex is a biopharmaceutical company developing treatments for pain conditions.
Scilex markets ZTlido®, a prescription topical lidocaine product, and develops candidates for lumbar radicular pain, acute low back pain, and chronic pain. Founded in 2011, the California company is a subsidiary of Sorrento. In March 2022, Vickers Vantage Corp. I agreed to merge with Scilex.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in